MicroRNA-221 is Required for Proliferation of Mouse Embryonic Stem Cells via P57 Targeting

Stem Cell Reviews and Reports

Volumn 11, Issue 1, 2015, Pages 39-49

  Li, Jin ^a   Bei, Yihua ^a   Liu, Qi ^b   Lv, Dongchao ^a   Xu, Tianzhao ^a   He, Yanyun ^a   Chen, Ping ^a   Xiao, Junjie ^a  

^a SHANGHAI UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Microrna 221; Microrna 222; Mouse embryonic stem cells; P57; Proliferation

Indexed keywords

ALKALINE PHOSPHATASE; CDKN1C PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1C; HOMEODOMAIN PROTEIN; MICRORNA; MIRN221 MICRORNA, MOUSE; NANOG PROTEIN, MOUSE; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, MOUSE; SOX2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CYTOLOGY; EMBRYOID BODY; EMBRYONIC STEM CELL; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; MOUSE; NECROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P57; EMBRYOID BODIES; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HOMEODOMAIN PROTEINS; MICE; MICRORNAS; MICROSCOPY, CONFOCAL; NECROSIS; OCTAMER TRANSCRIPTION FACTOR-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOXB1 TRANSCRIPTION FACTORS; TIME FACTORS;

EID: 84934271111     PISSN: 26293269     EISSN: 26293277     Source Type: Journal    
DOI: 10.1007/s12015-014-9543-y     Document Type: Article

References (28)

1. Yang, A., Shi, G., Zhou, C., et al. (2011). Nucleolin maintains embryonic stem cell self-renewal by suppression of p53 protein-dependent pathway. The Journal of Biological Chemistry, 286, 43370–43382.
2. Ho, L., Ronan, J. L., Wu, J., et al. (2009). An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proceedings of the National Academy of Sciencesof the United States of. America, 106, 5181–5186.
3. Wang, Y., & Blelloch, R. (2009). Cell cycle regulation by MicroRNAs in embryonic stem cells. Cancer Research, 69, 4093–4096.
4. Nishii, T., Oikawa, Y., Ishida, Y., Kawaichi, M., & Matsuda, E. (2012). CtBP-interacting BTB zinc finger protein (CIBZ) promotes proliferation and G1/S transition in embryonic stem cells via Nanog. The Journal of Biological Chemistry, 287, 12417–12424.
5. Heo, J. S., Lee, Y. J., & Han, H. J. (2006). EGF stimulates proliferation of mouse embryonic stem cells: involvement of Ca2+ influx and p44/42 MAPKs. The American Journal of Physiology- Cell Physiology, 290, 123–133.
6. 2+ channels in mouse embryonic stem cells: modulation during cell cycle and contribution to self-renewal. The American Journal of Physiology- Cell Physiology, 302, C494–504.
7. Raz, R., Lee, C. K., Cannizzaro, L. A., D'Eustachio, P., Levy, D. E., & Levy, D. E. (1999). Essential role of STAT3 for embryonic stem cell pluripotency. Proceedings of the National Academy of Sciencesof the United States of America, 96, 2846–2851.
8. Ma, T., Wang, Z., Guo, Y., & Pei, D. (2009). The C-terminal pentapeptide of nanog tryptophan repeat domain interacts with Nac1 and regulates stem cell proliferation but not pluripotency. The Journal of Biological Chemistry, 284, 16071–16081.
9. Xu, J., Zhao, J., Evan, G., Xiao, C., Cheng, Y., & Xiao, J. (2012). Circulating microRNAs: novel biomarkers for cardiovascular diseases. Journal of Molecular Medicine, 90, 865–875.
10. Seeger, F. H., Zeiher, A. M., & Dimmeler, S. (2013). MicroRNAs in stem cell function and regenerative therapy of the heart. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 1739–1746.
11. Li, J., Xu, J., Cheng, Y., Wang, F., Song, Y., & Xiao, J. (2013). Circulating microRNAs as mirrors of acute coronary syndromes: MiRacle or quagMire? Journal of Cellular and Molecular Medicine, 17, 1363–1370.
12. Mayoral, R. J., Deho, L., Rusca, N., Bartonicek, N., Saini, H. K., Enright, A. J., & Monticelli, S. (2011). MiR-221 influences effector functions and actin cytoskeleton in mast cells. PloS One, 6, e26133.
13. Xiao, J., Liang, D., Zhang, H., et al. (2012). MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells. Journal of Molecular and Cellular Cardiology, 53, 751–759.
14. Xiao, J., Liang, D., Zhang, Y., et al. (2011). MicroRNA expression signature in atrial fibrillation with mitral stenosis. Physiological Genomics, 43, 655–664.
15. Wong, Q. W. L., Ching, A. K. K., Chan, A. W. H., et al. (2010). MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clinical Cancer Research, 16, 867–875.
16. Pineau, P., Volinia, S., McJunkin, K., et al. (2010). miR-221 overexpression contributes to liver tumorigenesis. Proceedings of the national academy of sciencesof the united states of. America, 107, 264–269.
17. Tan, L., Yu, J. T., & Hu, N. (2013). Non-coding RNAs in Alzheimer’s disease. Molecular Neurobiology, 47, 382–393.
18. Chen, S. L., Zheng, M. H., Shi, K. Q., Yang, T., & Chen, Y. P. (2013). A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job. BioDrugs, 27, 25–34.
19. Liu, X., Cheng, Y., Zhang, S., Lin, Y., Yang, J., & Zhang, C. (2009). A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circulation Research, 104, 476–487.
20. Liu, X., Cheng, Y., Yang, J., Xu, L., & Zhang, C. (2012). Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. Journal of Molecular and Cellular Cardiology, 52, 245–255.
21. Sage, C., Nagel, R., Egan, D. A., et al. (2007). Regulation of the p27 (Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO Journal, 26, 3699–3708.
22. Fornari, F., Gramantieri, L., Ferracin, M., et al. (2008). MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene, 27, 5651–5661.
23. Guo, X., Liu, Q., Wang, G., et al. (2013). MicroRNA-29b is a novel mediator of Sox2 function in the regulation of somatic cell reprogramming. Cell Research, 23, 142–156.
24. Chen, D., Farwell, M. A., & Zhang, B. (2010). MicroRNA as a new player in the cell cycle. Journal of Cellular Physiology, 225, 296–301.
25. Zhang, J., Han, L., Ge, Y., et al. (2010). miR-221/222 promote malignant progression of glioma through activation of the Akt pathway. International Journal of Oncology, 36, 913–920.
26. Yu, B., Zhou, S., Wang, Y., et al. (2012). miR-221 and miR-222 promote Schwann cell proliferation and migration by targeting LASS2 after sciatic nerve injury. Journal of Cell Science, 125, 2675–2683.
27. Radojicic, J., Zaravinos, A., Vrekoussis, T., Kafousi, M., Spandidos, D. A., & Stathopoulos, E. N. (2011). MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle, 10, 507–517.
28. Tsai, Z. Y., Singh, S., Yu, S. L., et al. (2010). Identification of microRNAs regulated by activin a in human embryonic stem cells. Journal of Cellular Biochemistry, 109, 93–102.